Skip to content
SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%
Market News

Moderna Shares Rocket 110% Pre-Market As Cancer Drug Trial Success

Business - Latest - Google News · August 19, 2026

Moderna Shares Rocket 110% Pre-Market As Cancer Drug Trial Success  NDTV ProfitModerna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock is soaring.  MarketWatchModerna Shares Skyrocket 125% Toward Best Day Ever—Here’s Why  ForbesPromising Results for mRNA Cancer Vaccine from Moderna and Merck  Time MagazineBrookline reiterates Moderna stock rating on positive melanoma data By Investing.com  Investing.com India

View original source →

More News

New BMW 3 Series Debuts – 437 Hp M350, Electric i3 912 Km Range, Hybrid In 2027
Another warning sign for China’s economy: falling consumer credit
Car Retail Sales Sep 2026 – Maruti, Mahindra, Tata, Hyundai, Toyota, Kia, Skoda VW, MG, Honda
Fairfax ropes in Deepak Parekh, Paresh Sukthankar as advisers to IDBI Bank